| | | 2月24日重要公告摘要 | | --- | --- | --- | | 类型 | 公司 | 主要内容 | | 今日聚焦 | 长芯博创 游 中科曙光 | 拟收购上海鸿辉光联通讯技术有限公司93.81%股权 布局光通信领域产! 2025年净利21.13亿元 同比增长11% | | | 通威股份 | 筹划购买丽豪清能100%股权 股票停牌 | | | 东阳光 | 筹划收购东数一号控制权 后者为收购秦淮数据而设立的主体 | | 投资&签约 | 大族激光 | 拟1.5亿美元在东南亚设立海外运营中心 | | 增减持&回购 | 天奇股份 | 董事沈保卫2025年12月30日-2026年2月13日减持25. 38万股 | | 经营&业绩 | 光线传媒 50% | 电影《惊蛰无声》票房收入约为8.67亿元 超最近一个会计年度营业收. | | 合同&项目中标 | 渤海租赁 | 控股子公司出售24架附带租约的飞机租赁资产 市场价格约为15. 89亿美 | | 融资定增 | ST人福 | 拟向控股股东定增募资不超35亿元 | | 股价异动 | 豫能控股 | 不会合并先天算力财务报表 主营业务目前仍为火力发电 | | 其他 ...

Mergers and Acquisitions - Tongwei Co., Ltd. is planning to acquire 100% equity of Lihau Qingneng, resulting in a stock suspension [1] - Dongyangguang is planning to acquire control of Dongshu No. 1, which is controlled by its wholly-owned subsidiary Yichang Dongshu No. 3 Investment Co., Ltd. [1] - Changxin Bochuang intends to acquire 93.8108% equity of Shanghai Honghui Guanglian Communication Technology Co., Ltd. for 375 million, aiming to expand its product line in the upstream of the optical communication industry and enhance profitability and sustainability [1] Share Buybacks - Conch Cement's controlling shareholder, Conch Group, plans to increase its stake in the company by 700 million to 1.4 billion [2] Foreign Investment and Daily Operations - Dazhu Laser plans to establish an overseas operation center in Southeast Asia with an investment of 150 million [3] - Yida Co., Ltd.'s subsidiary, Taixing Yida, has obtained a project filing certificate for an annual production of 200,000 tons of epoxy propylene (ethylene) derivative products [4] - Light Media reported that as of February 23, 2026, the cumulative box office revenue of the film "Fast Life 3" is approximately 2.926 billion, with the company's revenue from this film estimated between 43 million to 53 million. The film "Silent Awakening" has a box office revenue of approximately 867 million, with company revenue estimated between 5.2 million to 6.6 million [4] - Happiness Blue Sea reported a total revenue of approximately 790,000 to 1.02 million from the films "Fast Life 3" and "Boon Year" [4] Performance Changes - Zhongke Shuguang expects total operating revenue of 14.97 billion in 2025, a year-on-year increase of 13.86%, with net profit attributable to shareholders of the listed company at 2.113 billion, a year-on-year increase of 10.54% [5]

每经AI快讯，2月24日，怡达股份（300721）(300721.SZ)公告称，公司控股子公司泰兴怡达取得江苏省 投资项目备案证，项目名称为年产20万吨环氧丙(乙)烷衍生产品项目，项目总投资为6.42亿元，计划开 工时间为2026年。项目建成后，将形成年产20万吨高端专用醇醚及醇醚酯的生产能力，包括5万吨湿电 子化学品。 ...

Group 1 - Fuda Alloy's controlling shareholder Wang Dawu plans to reduce his stake by up to 3% of the company's total shares, amounting to a maximum of 406.34 million shares, due to personal funding needs [1] - ST Songfa's subsidiary signed contracts for the construction of 17 vessels, with a total contract value between 1.6 billion to 1.8 billion USD [2] - Pairui Co. signed a technical cooperation agreement with a university to develop large-capacity power semiconductor devices and related power electronic modules, effective for three years [3] Group 2 - Shuangliang Energy indirectly participates in commercial aerospace projects, supplying heat exchangers for SpaceX's fuel production system, with orders totaling approximately 1.39 million CNY [4] - Hangya Technology plans to issue convertible bonds to raise up to 600 million CNY for various projects, including an intelligent manufacturing base in Malaysia [5] - Yuhua Development is publicly selling assets with a base price of 251 million CNY for residential properties [6] Group 3 - Penghui Energy plans to invest 2.1 billion CNY in a new battery production project in Zhengyang County, Henan Province, focusing on high-performance battery products [7] - Haige Communication's shareholder Yang Haizhou intends to reduce his stake by up to 0.1624% of the company's total shares [8] - Yaoshi Technology's controlling shareholder pledged 5.13% of shares to repay loans, with a pledge period from February 10, 2026, to February 2, 2027 [9][10] Group 4 - Hanyu Pharmaceutical received FDA approval for its drug Acetate Glatiramer Injection, used for treating relapsing multiple sclerosis [11] - Baiyao Tai's GoliMab Injection received EMA approval for various indications, including rheumatoid arthritis and ulcerative colitis [12] - Jiangxi Tungsten Equipment plans to issue A-shares to raise up to 1.882 billion CNY for acquisitions [13] Group 5 - Hesong New Materials expects to recognize asset impairment provisions between 23.6 million to 28.5 million CNY for 2025 [14] - ST Meichen's subsidiary is involved in two major lawsuits with a total amount of approximately 31.9 million CNY [15] - China Coal Energy reported a 7.3% year-on-year decline in coal sales for January 2026, with total sales of 20.05 million tons [16] Group 6 - Yida Co. plans to adjust its epoxy propylene derivative project, reducing the total investment from 845 million CNY to 642 million CNY [17] - Fosun Pharma's subsidiary received approval for a clinical trial of HLX15-SC for multiple myeloma treatment [18][19] - Yinfeng Communication's board members and executives have terminated their share reduction plan [20] Group 7 - Huazhong High-tech has waived its preferential purchase rights for a fund, extending the investment period from three to four years [21] - Warner Pharmaceuticals plans to participate in a national drug procurement program, with expected sales of 176 million CNY [22] - Changling Hydraulic announced a tender offer to acquire 12% of its shares at a price of 35.82 CNY per share [23] Group 8 - ST Chuan Zhi's stock may face delisting due to financial data falling below regulatory thresholds [24] - Tian Pharmaceutical and its subsidiaries are participating in a national drug procurement program, with expected sales of 323 million CNY [25] - China Metallurgical Group signed new contracts worth 73.65 billion CNY in January 2026 [26] Group 9 - Torus plans to invest 21.2 million CNY in a venture capital fund focused on artificial intelligence [27] - Shangwei Co. received a government subsidy of 1.764 million CNY, representing 10.79% of its net profit for 2024 [28] - Hanghua Co. reported a 21.97% decline in net profit for 2025, with total revenue of 1.249 billion CNY [29] Group 10 - Huaxia Bank reported a 1.72% decline in net profit for 2025, with total revenue of 91.914 billion CNY [30] - Guotou Fengle plans to transfer 51% of its stake in Hubei Fengle Ecological Fertilizer to optimize management [31] - Huaru Technology is co-investing in a fund with a total commitment of 20 million CNY [32] Group 11 - Jindike reported a loss of 173 million CNY for 2025, despite a 40.13% increase in revenue [33] - Zhenong Co. announced a 0.52% increase in shares held by a major shareholder [34] - Maike Audi plans to recognize asset impairment provisions of approximately 52.55 million CNY [35] Group 12 - Fuan Pharmaceutical's subsidiary is expected to be selected for a national drug procurement program, with projected sales of 680 million CNY [36] - Rundu Co. is participating in a national drug procurement program, with some products expected to be selected [37] - Changqing Co. has postponed its large-scale die-casting project to March 2027 due to customer requirements [38] Group 13 - Pan Asia Micro透 received a patent for a graphene-based automotive headlight defogging device [39] - Luan An Huan Neng reported a 17.1% increase in raw coal production for January 2026, totaling 5 million tons [40] - Guangji Pharmaceutical received a drug registration certificate for Mecobalamin Tablets [41] Group 14 - Ruifeng New Materials announced the resignation of its deputy general manager for personal reasons [42] - Zhiguang Electric's subsidiary signed a procurement contract for energy storage equipment worth 210.4 million CNY [43] - Youyan Powder Materials reported a 19.41% increase in net profit for 2025 [44] Group 15 - Jincheng reported a 22.2% increase in net profit for 2025, with total revenue of 253 million CNY [46]